Final Open Mic Showcase Features Cancer Comedy, Other Acts

Video

The third and final installment of the CURE® Open Mic Showcase features comedy, essay readings and videos from patients with cancer.

This is the third and final installment of the CURE® Open Mic Showcase — a series of videos featuring patients, survivors and caregivers showing off their artistic talents in acts that relate to their cancer experiences.

If you missed the first two episodes, they can be found here:

(0:25) The first act in this installment of the Open Mic Showcase is from Summer Golden, a woman who was diagnosed with myelofibrosis — a type of cancer that originates in the bone marrow — in 2017, just as she was learning the art of stand-up comedy. She submitted a short clip of one of her comedy acts where she discussed life with an incurable blood cancer — including her unorthodox hairstyle.

(3:37) Khevin Barnes, a CURE® contributor and male breast cancer survivor, submitted another segment of “Survive and Thrive Live,” his short series of videos about life with male breast cancer. This one is called, “The Breast Cancer Minute,” and in it, he discusses how his career as a stage magician — which included fooling people nearly every day — is not too different from his experience with male breast cancer.

(6:27) The next performance also comes from a CURE® contributor, Linda Cohen. Linda was diagnosed with small lymphocytic leukemia in 2009 and continued to bake bread every week as a source of comfort. Here, watch her read one of her essays, “Can Baking Bread By Cancer Therapy?

(10:59) The final act features Pamela McColloch, a podcaster and cancer survivor, reading her article, “Whisperings.” Pamela explained that when she was growing up, the word “cancer” was hardly said out loud — it was only whispered. In her reading, she recounts her first experience hearing the word when she was 9 years old. Decades later. when she received her own cancer diagnosis, she held on to what her 9-year-old self was taught.

CURE® would sincerely like to thank all readers who submitted to the first Open Mic Showcase. It is because of them that this series was a great success!

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content